Voluntary medical device correction: Freestyle Libre
Apr. 2023Important Notices
Abbott has initiated a voluntary medical device correction for readers that are used as part of the FreeStyle Libre, FreeStyle Libre 14 Day, and FreeStyle Libre 2 Flash glucose monitoring systems. These systems continuously measure the blood glucose levels of individuals with diabetes. Read more about the voluntary medical device correction for Freestyle Libre.
Recent Announcements
CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care
Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.Sep. 2026Education/Webinars
Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)
Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).Sep. 2026Pharmacy Updates
Voluntary nationwide recall: Dextrose (Baxter – August 2026)
Baxter International Inc. is recalling one lot (lot Y495066) of 70% Dextrose Injection. Dextrose is used to replenish calories and fluid in certain situations.Sep. 2026Pharmacy Updates